US Executive Compensation Proxy SEC Filings — May 21, 2026

21-05-2026

All In FutureTech Alliance, Inc. (formerly Allied Gaming & Entertainment Inc.) filed a definitive proxy statement (DEF 14A) for a special meeting of stockholders to be held virtually on June 1, 2026. The sole proposal is to approve a reverse stock split of common stock at a ratio ranging from 1-for-2 to 1-for-25, with the exact ratio and timing to be determined by the board of directors. As of the record date (May 14, 2026), there were 37,016,657 shares outstanding. The board recommends voting FOR the proposal.

• · Special meeting will be held virtually on June 1, 2026 at 10 a.m. Eastern Time at www.virtualshareholdermeeting.com/AGAE2026SM2.
• · Stockholders of record as of May 14, 2026 are entitled to vote.
• · Online check-in begins at 9:30 a.m. Eastern Time on meeting date.
• · Reverse split ratio range: 1-for-2 to 1-for-25, with board discretion on exact ratio and timing.
• · Proxy materials first mailed on or about May 21, 2026.
• · Brokers will lack discretionary authority to vote on this non-routine proposal if instructions are not received.
• · If no specific choices are made on a proxy, shares will be voted as recommended by the board (FOR).
• · No other matters are expected to be brought before the meeting.

21-05-2026

Barnwell Industries, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for a date to be determined, with a record date of May 4, 2026, and 14,338,575 shares of common stock issued and outstanding. The meeting will include six proposals: election of directors, approval of amendments to the 2018 Equity Incentive Plan, ratification of equity awards granted in excess of individual share limits, an advisory vote on executive compensation, an advisory vote on the frequency of the say-on-pay vote, and ratification of Weaver and Tidwell, L.L.P. as the independent auditor for fiscal year 2026. The proxy statement provides detailed executive compensation information for the fiscal year ended September 30, 2025, but the filing does not include specific financial performance metrics or period-over-period comparisons, limiting the ability to assess company performance trends.

• · The proxy materials are being distributed on or about May 20, 2026.
• · Stockholders of record as of May 4, 2026 are entitled to vote.
• · A quorum requires a majority of issued and outstanding shares.
• · Proposal 1 (Election of Directors) requires a plurality vote; abstentions and broker non-votes have no effect.
• · Proposal 2 (Amendments to 2018 Plan) requires a majority of shares present; abstentions count as votes against.
• · Proposal 3 (Ratification of Excess Awards) requires a majority of shares present; abstentions count as votes against.
• · Proposal 4 (Advisory Say-on-Pay) is non-binding and requires a majority of shares present; broker non-votes have no effect.
• · Proposal 5 (Frequency of Say-on-Pay) is advisory and non-binding.
• · Proposal 6 (Ratification of Auditor) is a routine matter where brokers may vote without instructions.
• · No cumulative voting rights exist for common stockholders.

21-05-2026

TIC Solutions, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders to be held virtually on July 1, 2026. The meeting will include the election of eleven directors and ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. The filing highlights a separated CEO and Board Co-Chairmen structure, with a majority of directors deemed independent, and notes that the Board held ten meetings in 2025 with strong director attendance.

• · The record date for voting is May 11, 2026.
• · The proxy materials and 2025 Annual Report on Form 10-K are available online at www.proxyvote.com.
• · The Board has a mandatory retirement age for independent directors.
• · The Audit Committee held 4 meetings in 2025.
• · The Company has a majority vote standard for director elections.
• · Restrictions on hedging and pledging of shares by executive officers and directors are in place.

21-05-2026

Centurion Acquisition Corp. filed a definitive proxy statement (DEF 14A) on May 21, 2026, for an Extraordinary General Meeting scheduled on June 9, 2026. The primary proposal is to extend the deadline to complete an initial business combination from June 12, 2026 to June 12, 2027 (the Extension Proposal). The trust account holds approximately $312 million, implying a redemption price of ~$10.85 per public share. However, the company faces a significant risk of failing to complete a business combination by the current deadline, and the extension requires approval from holders of at least two-thirds of outstanding ordinary shares, with insiders holding only 20%.

• · The closing prices on Record Date (May 6, 2026): units $10.80, public shares $10.84, warrants $0.19.
• · Redemption requests must be submitted by 5:00 p.m. ET on June 5, 2026 (two business days before the meeting).
• · If the Extension is not approved and no business combination is completed by June 12, 2026, the company will redeem public shares and warrants will expire worthless.
• · Insiders (Sponsor, directors, officers) hold 7,187,500 Founder Shares (Class B), representing 20% of outstanding ordinary shares.
• · Approval of Extension Proposal requires a special resolution (at least two-thirds of votes cast).
• · Approval of Adjournment Proposal requires an ordinary resolution (majority of votes cast).
• · The proxy statement was first mailed to shareholders on or about May 22, 2026.

21-05-2026

Cue Biopharma is holding a special meeting to seek stockholder approval for the issuance of up to 4,642,632 shares of common stock upon exercise of warrants issued in connection with a licensing transaction with Ascendant Health Sciences Ltd. and a related private placement. The licensing transaction grants Cue Biopharma exclusive worldwide rights (excluding China/Hong Kong/Macau/Taiwan) to an anti-IgE monoclonal antibody (Ascendant-221/UB-221) for an upfront payment of $15.0M and up to $676.5M in additional milestone payments plus tiered royalties. The filing reflects significant leadership turnover, with three CEO changes in recent months (Dr. Azam resigned March 2026, Mr. Passeri retired September 2025, Ms. Warren resigned April/May 2026) and the appointment of Dr. Shao-Lee Lin as President and CEO effective April 30, 2026.

• · The 1-for-30 reverse stock split was effected on April 23, 2026 and all share figures in the filing reflect this adjustment.
• · Weighted-average exercise price of outstanding options/warrants/rights under stockholder-approved plans is $117.98 per share.
• · The Ascendant Purchase Agreement (Initial Closing) occurred on May 4, 2026, issuing pre-funded warrants for 551,724 shares at $0.001 exercise price.
• · In addition to the Licensor warrants, pre-funded warrants for 2,727,272 shares and warrants for 1,363,636 shares were issued to accredited investors in a related private placement.
• · Sublicensing revenues within first 18 months would be shared with Licensor at 20%-40% rates.
• · In a change of control within 18 months, milestone payments accelerate up to $215.0 million.
• · Bleichroeder LP holds a 9.99% beneficial ownership stake and has warrants for an additional 147,749 shares subject to beneficial ownership limitations.
• · As of December 31, 2025, only 12,170 shares remained available for future issuance under equity compensation plans, indicating minimal equity grant capacity from existing plans.
• · Three CEO changes occurred within approximately 12 months: Passeri retired Sep 2025, Azam resigned Mar 2026, Warren resigned Apr/May 2026, succeeded by Lin on Apr 30, 2026.

21-05-2026

Edible Garden AG Inc. filed a Definitive Proxy Statement (DEF 14A) on May 21, 2026, for its Annual Meeting of Stockholders to be held virtually on June 17, 2026. Key proposals include electing five director nominees, ratifying CBIZ CPAs P.C. as independent auditor for FY2026, and approving a reverse stock split of common stock in a range of 1-for-5 to 1-for-250 at the Board's discretion. The filing also notes 5,469,314 shares of common stock outstanding as of the May 6, 2026 record date, with Series B Preferred Stock entitled to vote up to 130,549 shares (capped at 9.99% of common stock).

• · Annual Meeting will be held virtually on June 17, 2026 at 10:00 a.m. Eastern Time; registration deadline is June 16, 2026 at 5:00 p.m. ET.
• · Record date for voting is May 6, 2026.
• · Proposal Three seeks approval to amend the Certificate of Incorporation to effect one or more reverse stock splits in a range of 1-for-5 to 1-for-250, at Board discretion, with an aggregate cap of 1-for-250 and effectiveness no later than one year from the meeting date.
• · Proposal Four is an adjournment proposal to solicit additional votes if needed for Proposals One, Two, or Three.
• · Board recommends a vote FOR all proposals.
• · No other matters are expected to be presented at the meeting as of the filing date.

21-05-2026

Eaton Vance Enhanced Equity Income Fund filed a Definitive Proxy Statement (DEF 14A) on May 21, 2026, for its Annual Meeting of Shareholders scheduled for July 21, 2026. The main item is the election of three Class I Trustees: Alan C. Bowser, Cynthia E. Frost, and Scott E. Wennerholm. As of the May 7, 2026 record date, no shareholder owned 5% or more of the fund's 41,001,748 outstanding common shares, and insider (trustee/officer) ownership was under 1%. The meeting will be held in-person at One Post Office Square, Boston.

• · Shareholders as of May 7, 2026 record date are entitled to vote.
• · To attend the in-person meeting, record holders must show a valid photo ID; beneficial holders must also present a legal proxy from their intermediary.
• · The Board has fixed the trustee count at nine, divided into three staggered classes with three-year terms.
• · Election of trustees is non-cumulative; shareholders do not have appraisal rights.
• · Proxies with no voting instructions will be voted FOR each trustee nominee.
• · All nominees are current trustees who have consented to continue serving.

21-05-2026

Live Ventures Incorporated filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held on June 25, 2026. The meeting will address the election of five directors and the ratification of Frazier & Deeter as independent auditors for fiscal year ending September 30, 2026. The Board recommends voting FOR both proposals, and the record date is May 8, 2026, with 3,071,656 shares outstanding and entitled to vote.

• · The Annual Meeting will be held on June 25, 2026 at 10:00 a.m. Pacific Daylight Time at 8548 Rozita Lee Avenue, Suite 305, Las Vegas, Nevada 89113.
• · The record date for voting is May 8, 2026.
• · Proposal 1 (election of directors) is a non-routine matter; broker non-votes will not affect the outcome.
• · Proposal 2 (ratification of auditors) is a routine matter; abstentions will have the effect of a vote against.
• · The Company has adopted a Code of Business Conduct and Ethics, a Policy on Hedging, and an Insider Trading Policy.
• · The Board is required by Nasdaq listing standards to have a majority of independent directors.